Home

James S Scibetta

CIK 1383242 · President · last filed 2023-11-03

James S Scibetta is a President who has filed 49 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for MTNB, was dated Nov 3, 2023. Across all open-market trades the lifetime net is −$9.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $790.5K across reported positions. 21 SEC filings were submitted jointly with Pacira BioSciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$790.5K

Companies

4

Total Filings

49

Lifetime Open-Market Net

-$9.36M

Filer Profile

Reported Address
C/O BIOENVISION, INC.
345 PARK AVENUE, 41ST. FLOOR
NEW YORK, NY 10154
Related Filers
Pacira BioSciences, Inc. — 21 joint filings, latest 2017-06-07
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MTNB Director 12,519 $0.18 $2.3K $6.5K 18 2023-11-03
AQST Director 31,635 $4.78 $151.2K $87.0K 5 2021-06-17
PCRX President 25,118 $25.36 $637.0K -$9.46M 18 2017-06-07
NEPHROS INC (NEP) Delisted Director — $10.54 — $0 1 2007-12-04

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-11-03 MTNB Grant (A) — $0 EDGAR
2022-11-16 MTNB Grant (A) — $0 EDGAR
2021-11-02 MTNB Grant (A) — $0 EDGAR
2021-06-24 MTNB Mixed +28,800 $0 EDGAR
2021-06-17 AQST Grant (A) — $0 EDGAR
2020-11-10 MTNB Grant (A) — $0 EDGAR
2020-06-24 MTNB Other (J) +3,600 $0 EDGAR
2020-06-18 AQST Grant (A) — $0 EDGAR
2020-01-03 MTNB Grant (A) +8,260 $0 EDGAR
2019-11-05 MTNB Grant (A) — $0 EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.